R. Paul Beckett

Recent advances in matrix metalloproteinase inhibitor research

R. Paul Beckett, A DAVIDSON, Alan H. Drummond et al. · Drug Discovery Today · 1996 · 282 citations

Inhibitory Activity, Medicine, Metalloprotein +5

Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor

John M. Clements, R. Paul Beckett, Anthony Brown et al. · Antimicrobial Agents and Chemotherapy · 2001 · 233 citations · Full text

Bioorganic Chemistry, Antimicrobial Chemotherapy, Chemical Biology +16

Matrix metalloproteinase inhibitors 1998

R. Paul Beckett, Mark Whittaker · Expert Opinion on Therapeutic Patents · 1998 · 133 citations

Inhibitory Activity, Medicinal Chemistry, Novel Therapy +12

Discovery of (<i>R</i>)-2-Amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic Acid and Congeners As Highly Potent Inhibitors of Human Arginases I and II for Treatment of Myocardial Reperfusion Injury

M.C. Van Zandt, Darren L. Whitehouse, Adam Gołȩbiowski et al. · Journal of Medicinal Chemistry · 2013 · 84 citations · Full text

Lead Compounds, Pharmaceutical Science, Cardiovascular Pharmacology +19

Crystal and molecular structure of a trinuclear copper(<scp>II</scp>) complex: µ₃-hydroxo-tri-µ-(pyridine-2-carbaldehyde oximato)-µ₃-sulphato-tricopper(<scp>II</scp>)–16·3water

R. Paul Beckett, B.F. Hoskins · Journal of the Chemical Society Dalton Transactions · 1972 · 79 citations

Materials Science, Inorganic Chemistry, Crystal Structure +15